joincare pharmaceutical gr-a
(600380:Shanghai)
joincare pharmaceutical gr-a (600380) Snapshot
|
Open
CNY5.15
|
Previous Close
CNY5.19
|
|
|
Day High
CNY5.27
|
Day Low
CNY5.15
|
|
|
52 Week High
06/1/12 - CNY5.80
|
52 Week Low
09/3/12 - CNY3.47
|
|
|
Market Cap
8.1B
|
Average Volume 10 Days
9.4M
|
|
|
EPS TTM
CNY0.15
|
Shares Outstanding
1.5B
|
|
|
EX-Date
--
|
P/E TM
35.6x
|
|
|
Dividend
CNY0.04
|
Dividend Yield
--
|
Related News
joincare pharmaceutical gr-a (600380) Related Businessweek News
No Related Businessweek News Foundjoincare pharmaceutical gr-a (600380) Details
Joincare Pharmaceutical Industry Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China. It provides healthcare products under the Taitai, Jingxin, and Eagle brand names; antibiotic and their intermediates comprising 7ACA, 4AA, and F9; and prescription drugs in the areas of digestive tract, blood vessel of heart and brain, infection, tumor, nervous cerebrovascular section, urinary system, etc. The company also offers over the counter medicines, such as Dele-Livzon, a gastrointestinal drug; Live Bifidobacterium preparations; Yiketie, an oral ulcer drugs; Antiviral Oral Granule, a cold medicine; external use skin medicine; compound dexamethasone acetate cream, etc. In addition, it provides Chinese traditional medicines, chemical formulations, detection reagents, health food products, oral solution, fat eliminating capsule, oral band-aid, and effervescent tablets. Further, it offers troches, hard capsules, soft capsules, ointments, creams, gelatas, and solutions. The company also exports its products to the United States, Australia, Singapore, Malaysia, Taiwan, Marco, and Hong Kong. Joincare Pharmaceutical Industry Group Co., Ltd. was founded in 1992 and is headquartered in Shenzhen City, China.
joincare pharmaceutical gr-a (600380) Key Developments
Joincare Pharmaceutical Group Industry Co. Ltd. announced that they will report Q1, 2013 results on Apr 23, 2013
Joincare Pharmaceutical Group Industry Co. Ltd. announced that they will report fiscal year 2012 results on Apr 02, 2013
Joincare Pharmaceutical Group Industry Co. Ltd. at its directorate meeting held on March 01, 2013, proposed amendments to some clauses in articles of association.
| Recently Viewed | |||
| 600380:CH | CNY5.26 CNY | +0.07 | |
| Company | Last | Change | |
| No competitor information is available for 600380. | |||
| View Industry Companies | |||
Industry Analysis
600380
Industry Average
| Valuation | 600380 | Industry Range |
| Price/Earnings | 36.1x |
|
| Price/Sales | 1.3x |
|
| Price/Book | 2.1x |
|
| Price/Cash Flow | 36.1x |
|
| TEV/Sales | 0.4x |
|
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Northglenn, CO | Office DepotPosted: Mar 01
Sponsored Financial Commentaries
Sponsored Links
To contact JOINCARE PHARMACEUTICAL GR-A, please visit www.joincare.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








